The excess risk for atrial fibrillation increased with renal complications or with poor glycaemic control. Individuals with type 2 diabetes had an overall 35% higher risk of atrial fibrillation compared to age- and sex-matched controls from the general population. For individuals with HbA1c ≤ 6.9% (≤ 52 mmol/mol) and normoalbuminuria the excess risk vs controls was still increased, adjusted HR 1.16 (95% CI 1.14–1.19) p < 0.0001. The excess risk of atrial fibrillation in individuals with type 2 diabetes increased with worsening glycaemic control and renal complications. In the fully adjusted Cox regression, the risk of type 2 diabetes on incident atrial fibrillation was 28% greater vs controls, hazard ratio (HR) 1.28 (95% CI 1.26–1.30), p < 0.0001.
Women < 55 years old with type 2 diabetes had an IRR of 2.36 (95% CI 2.10–2.66), in relation to controls, whereas the corresponding value for men < 55 years old with type 2 diabetes was IRR 1.78 (95% CI 1.67–1.90). Overall, 8.9% of individuals with type 2 diabetes and 7.0% of controls were diagnosed with atrial fibrillation during follow-up, unadjusted incidence risk ratio (IRR) 1.35 (95% 1.33–1.36). MethodsĪ total of 421,855 patients with type 2 diabetes from the Swedish National Diabetes Registry and 2,131,223 controls from the Swedish Population Registry, matched for age, sex and county, were included and followed from Januto December 31, 2013. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.To examine the incidence of atrial fibrillation in individuals with type 2 diabetes compared with age- and sex-matched controls from the general population and its variation in relation to glycaemic control and renal function. Number of patients with a final diagnosis of ischaemic stroke, with documented atrial fibrillation, separated from hospital.Īustralian Commission on Safety and Quality in Health Careįurie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC et al. Number of patients with a final diagnosis of ischaemic stroke with documented atrial fibrillation who were prescribed oral anticoagulation therapy on separation from hospital. advance care directive is enacted and/or the patient is on a palliative care pathway).
The diagnosis of atrial fibrillation is in addition to the diagnosis of ischaemic stroke. I48.9 Atrial fibrillation and atrial flutter, unspecified.I48.4 Atypical atrial flutter (Type II atrial flutter).I48.3 Typical atrial flutter (Type I atrial flutter).
2011).Ĭlinical care standard indicators: acute strokeīoth the numerator and the denominator include patients with a final diagnosis of ischaemic stroke and atrial fibrillation.Ītrial fibrillation includes patients where Episode of care-principal diagnosis, code (ICD-10-AM 9th edn) ANN is one of the following: The administration of oral anticoagulation therapy, unless there are contraindications, is an established effective strategy in preventing recurrent stroke in patients with a high stroke risk, such as those with atrial fibrillation, or prior transient ischaemic attack (TIA) or stroke (Furie et al. Non-valvular atrial fibrillation is a common arrhythmia and an important risk factor for stroke. Proportion of ischaemic stroke patients with atrial fibrillation prescribed oral anticoagulants, where not contraindicated, on separation from hospital. Indicator 5c-Oral anticoagulants prescribed for atrial fibrillation on separation from hospital Acute stroke clinical care standard indicators: 5c-Oral anticoagulants prescribed for atrial fibrillation on separation from hospital Identifying and definitional attributes